The Truth About Hormone Replacement Therapy in 2024
The evidence on HRT has evolved dramatically. Here's what the latest research actually says about safety and benefits.
For decades, hormone replacement therapy carried a cloud of fear. The 2002 Women's Health Initiative study sent shockwaves through medicine, causing millions of women to abruptly stop therapy. But the story didn't end there — and the full picture is far more nuanced than the headlines suggested.
**What we know now:** The WHI studied older women (average age 63) using a specific oral synthetic progestogen combination. For most women who start HRT before age 60 or within 10 years of menopause onset, the evidence strongly supports a favorable benefit-risk profile.
**Benefits of HRT:** - Most effective treatment for vasomotor symptoms (hot flashes, night sweats) - Prevents bone loss and reduces fracture risk - Improves sleep, mood, and cognitive symptoms - May reduce risk of cardiovascular disease when started early - Improves vaginal and urinary health - Evidence of reduced all-cause mortality in women under 60
**The type matters:** Body-identical (micronized) progesterone has a different — and more favorable — risk profile than synthetic progestogens. Transdermal estrogen (patches, gels) avoids first-pass liver metabolism and carries a lower clot risk than oral forms.
**Who should be cautious:** Women with a personal history of hormone-sensitive breast cancer, uncontrolled cardiovascular disease, or active liver disease should discuss risks carefully with their provider.
The decision is individual. What matters is having an honest, evidence-based conversation about your personal risk factors and symptoms.